Hair Growth Claims Move Your Serum Into Drug Territory

A scalp serum with rosemary oil, peppermint, and biotin sounds like exactly the kind of product that belongs in a cosmetic notification. And formula-wise, it usually is. The problem shows up in the marketing copy, specifically the moment someone writes "stimulates hair regrowth" or "stops hair loss" on the label or the product page.

The claim, not the ingredient, is what triggers the drug pathway

None of the common botanical actives in a scalp serum, rosemary extract, peppermint oil, caffeine, biotin, are drugs by themselves. They can genuinely be included in a cosmetic formula. What changes everything is the claim attached to them. A cosmetic can describe how a product affects the hair's appearance, feel, or the scalp's condition in general, appearance-focused terms. It cannot claim to treat a medical condition like androgenetic alopecia, or claim to regrow hair, without crossing into drug territory, because at that point you're asserting a therapeutic effect on a recognized condition rather than a cosmetic benefit.

This is the same underlying logic that governs anti-dandruff shampoo and antiperspirant, both of which are typically treated as drugs rather than cosmetics because they claim to treat or prevent something specific, not just clean or improve appearance.

Where the line actually sits

Compare these two label statements for the same rosemary-and-caffeine scalp serum:

• "Nourishes the scalp and helps hair look fuller and healthier." Appearance and condition-focused, no medical claim. Reads as cosmetic.
• "Clinically shown to regrow hair and stop hair loss." Direct therapeutic claim about a recognized condition. Reads as a drug claim, and quite a serious one at that, since "clinically shown" also implies a level of substantiation most makers haven't actually done.

The gap between those two statements can be small in a marketing meeting and enormous in a regulatory sense. Words like "regrowth," "hair loss treatment," "reverses thinning," and "stops shedding" all lean toward the therapeutic side. Words like "supports a healthy-looking scalp," "helps hair appear thicker," and "conditions and strengthens" stay closer to cosmetic territory, though there's genuine judgment involved and borderline cases exist.

Why makers reach for growth claims anyway

It's an understandable instinct. Hair loss is an emotional, high-intent purchase category, and customers are searching for exactly the words that would tip a product into drug status: "regrowth," "hair loss," "thinning treatment." The commercially tempting language is often the regulatory dangerous language. A maker who writes honest, effective marketing copy aimed at what customers actually search for can end up describing a drug without ever intending to sell one.

This is worth sitting with for a second, because it's the same trap that shows up in acne-treatment face washes and anti-aging serums that promise to "reverse" wrinkles. The pattern repeats across categories: therapeutic-sounding claims about a named condition pull a product out of the cosmetic lane, regardless of how mild the actual formula is.

What a defensible cosmetic scalp product looks like

If you want to stay in cosmetic territory with a hair and scalp product, a few practical habits help:

1. Describe effects on appearance and feel (thicker-looking, fuller-feeling, nourished) rather than effects on a medical condition.
2. Avoid naming hair loss, alopecia, or thinning as a condition you treat, even indirectly through phrases like "fights hair loss."
3. Avoid clinical-sounding substantiation language ("clinically proven," "dermatologist-tested for regrowth") unless you genuinely have the drug-appropriate studies and pathway behind it.
4. Keep ingredient-level claims general. "Contains caffeine, known to invigorate the scalp" is safer than "caffeine stimulates follicles to regrow hair."

If you actually want to make a regrowth claim

Some ingredients used for hair loss do have a recognized drug pathway in certain markets, with defined active ingredients and monograph-level requirements. That's a genuinely different regulatory process from a cosmetic notification, with its own substantiation, labeling, and approval expectations, and it's worth researching specifically and separately if a real hair-loss treatment claim is the actual goal. Trying to back into that outcome through a cosmetic filing doesn't work, because the filing systems and the underlying legal categories are simply different tools for different jobs.

Keeping the notification honest

For makers staying in the cosmetic lane, the notification itself still needs the same care as any other product: accurate INCI names and concentrations for every active, including the botanical extracts and caffeine, checked against the Cosmetic Ingredient Hotlist, filed within the window after first sale. The claims discipline has to happen alongside that, not instead of it. A perfectly filed Cosmetic Notification Form doesn't protect you if the label makes a therapeutic claim the filing category was never meant to cover.

Cosmetic Comply handles the ingredient side of that work, mapping every component in a scalp serum to its correct INCI name and CAS number, screening it against the restricted list, and having a real reviewer sign off before the notification goes in, which frees you up to spend the harder thinking on getting the claims language right.